Effects of NMDA and Metabotropic Glutamate Receptors Antagonists in Working Memory Task in Rats

被引:0
作者
Novitskaya, Y. A. [1 ]
Dravolina, O. A.
Zvartau, E. E.
Danysz, W.
Bespalov, A. Y.
机构
[1] Pavlov State Med Univ, Dept Psychopharmacol, Valdman Inst Pharmacol, St Petersburg, Russia
关键词
schizophrenia; working memory; proactive interference; NMDA receptors; MK-801; metabotropic glutamate receptors; MTEP; rats; PROACTIVE-INTERFERENCE; PREPULSE INHIBITION; LOCOMOTOR-ACTIVITY; IN-VITRO; MGLUR5; MPEP; SUBTYPE-5; DEFICITS; POTENT; BRAIN;
D O I
暂无
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Glutamate, major excitatory neurotransmitter in mammalian CNS, acts via ionotropic and metabotropic receptors. In agreement with the results of in vitro studies that pointed at close interactions between ionotropic NMDA and metabotropic glutamate mGlu5 receptors, blockade of mGlu5 receptors was reported to enhance behavioral effects of NMDA receptor channel blockers. The present study aimed to study the effects of a highly selective mGluR5 antagonist MTEP, alone and in combination with NMDA receptor channel blocker MK-801, in rats trained to perform a delay-non-match-to-position task (working memory test). Acute administration of MK-801 (0.1 mg/kg) produced specific working memory impairment expressed as proactive interference (poor performance in the current trial due to the interfering influence of the experience in past trials). However, administration of MTEP (5.0 mg/kg), either alone or in combination with MK-801, had no appreciable effects. While these data clearly indicate little or no involvement of mGlu5 receptors in the mechanisms of working memory, present results demonstrate a robust experimental approach to study cognitive deficits associated with psychotomimetic drug treatment.
引用
收藏
页码:446 / 452
页数:7
相关论文
共 19 条
[1]   [3H]methoxymethyl-3-[(2-methylyl-1,3-thiazol-4-yl)ethynyl]pyridine binding to metabotropic glutamate receptor subtype 5 in rodent brain:: In vitro and in vivo characterization [J].
Anderson, JJ ;
Rao, SP ;
Rowe, B ;
Giracello, DR ;
Holtz, G ;
Chapman, DF ;
Tehrani, L ;
Bradbury, MJ ;
Cosford, NDP ;
Varney, MA .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2002, 303 (03) :1044-1051
[2]   The mGluR5 antagonist 2-methyl-6-(phenylethynyl)-pyridine (MPEP) potentiates PCP-induced cognitive deficits in rats [J].
Campbell, UC ;
Lalwani, K ;
Hernandez, L ;
Kinney, GG ;
Conn, PJ ;
Bristow, LJ .
PSYCHOPHARMACOLOGY, 2004, 175 (03) :310-318
[3]   Pharmacology and functions of metabotropic glutamate receptors [J].
Conn, PJ ;
Pin, JP .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1997, 37 :205-237
[4]   3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]-pyridine: A potent and highly selective metabotropic glutamate subtype 5 receptor antagonist with anxiolytic activity [J].
Cosford, NDP ;
Tehrani, L ;
Roppe, J ;
Schweiger, E ;
Smith, ND ;
Anderson, J ;
Bristow, L ;
Brodkin, J ;
Jiang, XH ;
McDonald, I ;
Rao, S ;
Washburn, M ;
Varney, MA .
JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (02) :204-206
[5]   [3H]-methoxymethyl-MTEP and [3H]-methoxy-PEPy:: Potent and selective radioligands for the metabotropic glutamate subtype 5 (mGlu5) receptor [J].
Cosford, NDP ;
Roppe, J ;
Tehrani, L ;
Schweiger, EJ ;
Seiders, TJ ;
Chaudary, A ;
Rao, S ;
Varney, MA .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (03) :351-354
[6]  
Dingledine R, 1999, PHARMACOL REV, V51, P7
[7]   PROACTIVE-INTERFERENCE EFFECTS ON SHORT-TERM-MEMORY IN RATS .1. BASIC PARAMETERS AND DRUG EFFECTS [J].
DUNNETT, SB ;
MARTEL, FL .
BEHAVIORAL NEUROSCIENCE, 1990, 104 (05) :655-665
[8]   Activation of group I mGluRs potentiates NMDA responses in rat hippocampal slices [J].
Fitzjohn, SM ;
Irving, AJ ;
Palmer, MJ ;
Harvey, J ;
Lodge, D ;
Collingridge, GL .
NEUROSCIENCE LETTERS, 1996, 203 (03) :211-213
[9]   Evidence that the metabotropic glutamate receptor 5 antagonist MPEP may act as an inhibitor of the norepinephrine transporter in vitro and in vivo [J].
Heidbreder, CA ;
Bianchi, H ;
Lacroix, LP ;
Faedo, S ;
Perdona, E ;
Remelli, R ;
Cavanni, P ;
Crespi, F .
SYNAPSE, 2003, 50 (04) :269-276
[10]   The mGluR5 antagonist MPEP, but not the mGluR2/3 agonist LY314582, augments PCP effects on prepulse inhibition and locomotor activity [J].
Henry, SA ;
Lehmann-Masten, V ;
Gasparini, F ;
Geyer, MA ;
Markou, A .
NEUROPHARMACOLOGY, 2002, 43 (08) :1199-1209